| Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study MC Schneeweiss, R Wyss, S Schneeweiss, P Anand, Y Jin, E Dicesare, ... Journal of the American Academy of Dermatology 90 (1), 134-137, 2024 | 4 | 2024 |
| Patient characteristics associated with using transcatheter left atrial appendage occlusion versus oral anticoagulants for atrial fibrillation KJ Lin, DE Singer, J Avorn, EK Heist, SK Sreedhara, P Anand, Y Zhang, ... Circulation: Cardiovascular Quality and Outcomes 17 (3), e010279, 2024 | 2 | 2024 |
| Comparison of EHR Data‐Completeness in Patients with Different Types of Medical Insurance Coverage in the United States P Anand, Y Zhang, D Merola, Y Jin, SV Wang, J Lii, J Liu, KJ Lin Clinical Pharmacology & Therapeutics 114 (5), 1116-1125, 2023 | 2 | 2023 |
| Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis P Anand, S Schneeweiss, A Mostaghimi, MC Schneeweiss Pharmacoepidemiology and drug safety 32 (5), 567-576, 2023 | 2 | 2023 |
| Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis P Anand, S Schneeweiss, A Mostaghimi, MC Schneeweiss Pediatric dermatology 40 (1), 132-134, 2023 | 2 | 2023 |
| A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring System MC Schneeweiss, RJ Glynn, R Wyss, P Anand, Y Jin, J Landon, ... Journal of Investigative Dermatology, 2024 | 1 | 2024 |
| Validation of alopecia coding in US claims data among women of childbearing age MC Schneeweiss, A Mostaghimi, S Chiuve, S Schneeweiss, P Anand, ... Pharmacoepidemiology and Drug Safety 33 (4), e5782, 2024 | 1 | 2024 |
| Identifying Dementia Severity Among People Living With Dementia Using Administrative Claims Data P Anand, Y Zhang, K Ngan, M Mahesri, G Brill, DH Kim, KJ Lin Journal of the American Medical Directors Association 25 (9), 105129, 2024 | | 2024 |
| A Dynamic Prognostic Model for Identifying Vulnerable COVID‐19 Patients at High Risk of Rapid Deterioration P Anand, E D'Andrea, W Feldman, SV Wang, J Liu, G Brill, E DiCesare, ... Pharmacoepidemiology and Drug Safety 33 (8), e5872, 2024 | | 2024 |
| 43219 Joint pain in patients with atopic dermatitis receiving dupilumab versus mycophenolate or cyclosporine M Schneeweiss, R Wyss, J Merola, P Anand, S Schneeweiss, R Glynn Journal of the American Academy of Dermatology 89 (3), AB185, 2023 | | 2023 |
| Utilization patterns of systemic immunomodulating drugs in patients with atopic dermatitis in clinical practice M Schneeweiss, P Anand, S Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 110-110, 2022 | | 2022 |
